Cardiometabolic criteria as predictors and treatment targets of liver‐related events and cardiovascular events in metabolic dysfunction‐associated steatotic liver disease

Nobuharu Tamaki, Takefumi Kimura, Shun‐ichi Wakabayashi, Takeji Umemura, Namiki Izumi, Rohit Loomba, Masayuki Kurosaki

Alimentary Pharmacology & Therapeutics · 2024 · 26 citations · 20 references

DOIFull text

Open access

Abstract

Cardiometabolic criteria can be used as predictors and treatment targets for cardiovascular event risk in MASLD. Developing predictors and therapeutic targets for liver-related events is a future challenge.

References

20